 | • レポートコード：MRC2305A105 • 出版社/出版日：Transparency Market Research / 2023年3月3日 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（納期：要問合せ） • 産業分類：医療 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本市場調査資料によると、世界の慢性完全閉塞用デバイス市場規模が、2023年の17億ドルから2031年には29億ドルまで年平均6.1%成長すると見込まれています。本資料は慢性完全閉塞用デバイスの世界市場について広く調査し、序論、仮定、調査方法、エグゼクティブサマリー、市場概要、新型コロナウイルス感染症分析、製品別（マイクロカテーテル、ガイドワイヤー、閉塞デバイス、リエントリーデバイス、その他）分析、エンドユーザー別（病院、外来手術センター、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、主要ポイントなどをまとめています。また、本資料には、Medtronic、Boston Scientific Corporation、Acrostak Int. Distr. Sàrl、Abbott、Asahi Intecc Co., Ltd.、Cardinal Health、Cook Medical、Merit Medical Systems、MicroPort Scientific Corporation、Penumbra, Inc.、Koninklijke Philips N.V.、Terumo India Private Limitedなどの企業情報が含まれています。 ・序論 ・仮定 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・新型コロナウイルス感染症分析 ・世界の慢性完全閉塞用デバイス市場規模：製品別 - マイクロカテーテルの市場規模 - ガイドワイヤーの市場規模 - 閉塞デバイスの市場規模 - リエントリーデバイスの市場規模 - その他製品別の市場規模 ・世界の慢性完全閉塞用デバイス市場規模：エンドユーザー別 - 病院における市場規模 - 外来手術センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の慢性完全閉塞用デバイス市場規模：地域別 - 北米の慢性完全閉塞用デバイス市場規模 - ヨーロッパの慢性完全閉塞用デバイス市場規模 - アジア太平洋の慢性完全閉塞用デバイス市場規模 - 中南米の慢性完全閉塞用デバイス市場規模 - 中東・アフリカの慢性完全閉塞用デバイス市場規模 ・競争状況 ・企業情報 ・主要ポイント |
Chronic Total Occlusion Devices Market – Scope of Report
TMR’s report on the global chronic total occlusion devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global chronic total occlusion devices market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global chronic total occlusion devices market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the chronic total occlusion devices market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global chronic total occlusion devices market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global chronic total occlusion devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global chronic total occlusion devices market.
The report delves into the competitive landscape of the global chronic total occlusion devices market. Key players operating in the global chronic total occlusion devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global chronic total occlusion devices market profiled in this report.
Key Questions Answered in Global Chronic Total Occlusion Devices Market Report
• What is the sales/revenue generated by chronic total occlusion devices across all regions during the forecast period?
• What are the opportunities in the global chronic total occlusion devices market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
Chronic Total Occlusion Devices Market – Research Objectives and Research Approach
The comprehensive report on the global chronic total occlusion devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global chronic total occlusion devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global chronic total occlusion devices market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Chronic Total Occlusion Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution /Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Chronic Total Occlusion Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Technological Advancements
5.3. Regulatory Scenario by Region/globally
5.4. COVID-19 Pandemic Impact on Industry
6. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Microcatheters
6.3.2. Guidewires
6.3.3. Crossing Devices
6.3.4. Re-entry Devices
6.3.5. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Chronic Total Occlusion Devices Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Chronic Total Occlusion Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product Type, 2017–2031
9.2.1. Microcatheters
9.2.2. Guidewires
9.2.3. Crossing Devices
9.2.4. Re-entry Devices
9.2.5. Others
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Chronic Total Occlusion Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Microcatheters
10.2.2. Guidewires
10.2.3. Crossing Devices
10.2.4. Re-entry Devices
10.2.5. Others
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Chronic Total Occlusion Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Microcatheters
11.2.2. Guidewires
11.2.3. Crossing Devices
11.2.4. Re-entry Devices
11.2.5. Others
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Hospitals
11.3.2. Ambulatory Surgical Centers
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Chronic Total Occlusion Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Microcatheters
12.2.2. Guidewires
12.2.3. Crossing Devices
12.2.4. Re-entry Devices
12.2.5. Others
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Hospitals
12.3.2. Ambulatory Surgical Centers
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Chronic Total Occlusion Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Microcatheters
13.2.2. Guidewires
13.2.3. Crossing Devices
13.2.4. Re-entry Devices
13.2.5. Others
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Hospitals
13.3.2. Ambulatory Surgical Centers
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2022
14.3. Company Profiles
14.3.1. Medtronic
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Type Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Boston Scientific Corporation
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Type Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Acrostak Int. Distr. Sàrl
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Type Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Abbott
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Type Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Asahi Intecc Co., Ltd.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Type Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Cardinal Health
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Type Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Cook Medical
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Type Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Merit Medical Systems
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Type Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. MicroPort Scientific Corporation
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Type Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Penumbra, Inc.
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Type Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. Koninklijke Philips N.V.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Type Portfolio
14.3.11.3. Financial Overview
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. Terumo India Private Limited
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Product Type Portfolio
14.3.12.3. Financial Overview
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. Teleflex Incorporated
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Product Type Portfolio
14.3.13.3. Financial Overview
14.3.13.4. SWOT Analysis
14.3.13.5. Strategic Overview
14.3.14. Becton, Dickinson and Company
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Product Type Portfolio
14.3.14.3. Financial Overview
14.3.14.4. SWOT Analysis
14.3.14.5. Strategic Overview
14.3.15. Reflow Medical
14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.15.2. Product Type Portfolio
14.3.15.3. Financial Overview
14.3.15.4. SWOT Analysis
14.3.15.5. Strategic Overview
14.3.16. Nitiloop
14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.16.2. Product Type Portfolio
14.3.16.3. Financial Overview
14.3.16.4. SWOT Analysis
14.3.16.5. Strategic Overview